Accendra Health (NYSE:ACH) has abandoned plans to establish an at-the-market equity issuance programme, citing recent market conditions, while also providing an updated timetable for appointing a successor to Chief Executive Christopher Pesicka. The proposed programme would have allowed Accendra to issue modest amounts of equity over time, with the proceeds intended to reduce debt.

ICU Medical (ICUI) delivered earnings and revenue surprises of +24.08% and +2.33%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Accendra Health Inc. (NYSE:ACH) is one of the 15 best NYSE penny stocks to buy according to hedge funds. On June 23, Accendra Health Inc. (NYSE:ACH) disclosed the final settlement of its previously disclosed offer, involving its outstanding 4.5% senior notes due 2029 and 6.625% senior notes due 2030. These have been exchanged with fresh […]

Investors need to pay close attention to ACH stock based on the movements in the options market lately.

Alchemy Pay (CRYPTO: $ACH) has added Illinois to its U.S. regulatory map, giving the fiat-crypto payments company a...

Accendra Health (ACH) said Wednesday that holders of nearly all of its outstanding 4.5% senior notes

Investors need to pay close attention to ACH stock based on the movements in the options market lately.

Despite a challenging quarter marked by a revenue decline, Accendra Health Inc (ACH) focuses on debt reduction and growth in key categories like sleep therapy and home respiratory care.

The press release, along with the first quarter 2026 supplemental slides, which we will refer to throughout the call are posted in the Investor Relations section of our website. Please note that during the call, we will make forward-looking statements that reflect the current views of sundra Health about our business, financial performance and future events.

Accendra Health, Inc. (NYSE:ACH) shares surged nearly 10% in premarket trading on Monday after the home-based healthcare company reported first-quarter 2026 earnings that came in ahead of analyst expectations.